The Effect of Myofascial Release Technique on the Treatment of Primary Dysmenorrhea in Psoas Muscle

Woman; Primary Dysmenorrhoea Clinical Trial

Official title:

The Effect of Myofascial Relaxation Technique on the Treatment of Primary Dysmenorrhea in Psoas Muscle

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04254510
• Other study ID #: MRT_Dysmenorrhea
• Status: Completed
• Phase: N/A
• Start date: February 10, 2020
• Est. completion date: April 20, 2020

Study information

• Verified date: February 2020
• Source: Istanbul Medipol University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Dysmenorrhea is a series of pathological symptoms associated with menstruation that interfere with daily activities such as abdominal cramps and pain in the menstrual period. General symptoms such as nausea, vomiting, lumbago, diarrhea and headache are also common. Primary dysmenorrhea refers to menstrual pain that does not depend on the underlying pathology. The kidneys act on the fascia of the psoas muscle. If the psoas muscle does not shorten and grow sufficiently, the kidneys may not move for a certain period of time and may experience ptosis. This causes venous ponding and may cause varicocele in men and primary dysmenorrhea in women. Techniques to be applied directly to the fascia of the psoas muscle can reduce symptoms of dysmenorrhea in women. In the literature review, no studies investigating the effectiveness of a treatment applied directly and only on the psoas muscle on primary dysmenorrhea were not found. This study can set an example for future studies. In our study, myofascial relaxation technique will be applied in women with primary dysmenorrhoea and its effect on pain will be examined.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 38
• Est. completion date: April 20, 2020
• Est. primary completion date: April 3, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 30 Years

Eligibility

Inclusion Criteria:

• The age range is 18-30,

• Intense pain compared to visual analog scale in the lower region of the abdomen during or just before the menstruation period (> 4),

• No pregnancy history,

• Not using drugs for dysmenorrhea symptoms

Exclusion Criteria:

• Not agreeing to participate in the study,

• Endometriosis, ovarian cyst, uterine fibroid, congenital malformation or pelvic inflammation,

• Having a diagnosis of secondary dysmenorrhea

Related Conditions & MeSH terms

• Dysmenorrhea
• Woman; Primary Dysmenorrhoea

Intervention

Other:
• Myofascial relaxation technique
Before the intervention, the number of days of the last menstrual cycle of all participants, the number of painful days throughout the cycle, pain intensity values according to the Visual Analogue Scale will be recorded, and the scores will be recorded in the participants. Technique of direct relaxation of fascia of both psoas muscles to the participants in the myofascial relaxation group since the end of the last cycle, 90-120 sec. It will be applied by the physiotherapist twice a week.

Locations

Country	Name	City	State
Turkey	Esra Pehli?van	Istanbul	Üsküdar

Sponsors (1)

Lead Sponsor	Collaborator
Istanbul Medipol University Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Visual analog scale	Pain intensity will be questioned by scale.For pain intensity, the scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale]) . To avoid clustering of scores around a preferred numeric value, numbers or verbal descriptors at intermediate points are not recommended	5 seconds